Mr. Rush brings more than 30 years of financial experience and expertise within the clinical research organization (CRO), biopharmaceutical, technology, and professional services industries. He joined Parexel International Corporation, a global CRO, as executive vice president and chief financial officer in 2018. Prior to joining Parexel, Mr. Rush served from 2013 to 2018 as executive vice president and chief financial officer of Syneos Health, Inc., a publicly traded biopharmaceutical services organization. Mr. Rush also was senior vice president and chief financial officer of Tekelec, Inc., a leading developer of telecommunications products and services acquired by Oracle. Mr. Rush’s experience also includes serving in various roles at Siebel Systems, Inc., Quintiles Transnational Corporation, PricewaterhouseCoopers, and Ernst & Young, where he developed extensive knowledge in financial operations, capital market transactions, financial reporting, and acquisitions.